Search Within

Population Sciences Research Program

  1. "Radiology, Department of"
  2. "Meeting abstract"
Formats
  1. Meeting Abstract (159)
Groups
  1. Radiology, Department of (159)
  2. Department of Medicine (117)
  3. Epidemiology and Biostatistics (100)
  4. Biostatistics Service (85)
  5. Solid Tumor Oncology Division (84)
  6. Body Imaging Service (77)

More Groups

People
  1. Steven Horwitz (34)
  2. Andrew Zelenetz (31)
  3. Paul Hamlin (29)
  4. Ariela Noy (26)
  5. David Straus (26)
  6. Heiko Schoder (26)

More People

Years
  1. 2024 (2)
  2. 2023 (13)
  3. 2022 (12)
  4. 2021 (11)
  5. 2020 (14)
  6. 2019 (12)

More Years

Publications
  1. Journal of Clinical Oncology (60)
  2. Blood (20)
  3. Neuro-Oncology (11)
  4. Cancer Research (9)
  5. Annals of Surgical Oncology (8)
  6. Annals of Oncology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (60)
  2. American Society of Hematology (20)
  3. Oxford University Press (18)
  4. American Association for Cancer Research (14)
  5. Elsevier Inc. (11)
  6. Springer (9)

More Publishers

Results (159)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Inter-reader agreement of imaging response after neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma
    Meeting Abstract

    Heiselman, J. S.; Horvat, N.; Agridag-Upcinar, B.; Yildirim, O.; Ecker, B. L.; O'Reilly, E. M.; Drebin, J.; Balachandran, V. P.; Kingham, T. P.; D'Angelica, M. I.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • Vascular emergencies in patients with hepatic arterial infusion pumps: A single-center retrospective study
    Meeting Abstract

    Blume, H.; Jain, S.; Schleimer, L.; Covey, A.; Zhao, K.; Park, J.; Jarnagin, W.; Wei, A.; Soares, K.; Kingham, P.; more...
    Journal of Vascular and Interventional Radiology (2024)

    Fulltext@MSK | Save
  • Tumor volume growth rates and doubling times during active surveillance of IDH-mutant low-grade glioma
    Meeting Abstract

    Bhatia, A.; Moreno, R.; Reiner, A.; Nandakumar, S.; Walch, H.; Thomas, T.; Nicklin, P.; Choi, C.; Skakodub, A.; Malani, R.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Index lesion dosimetry for (177)Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer
    Meeting Abstract

    Grkovski, M.; O'Donoghue, J.; Imber, B.; Andl, G.; Tu, C.; Lafontaine, D.; Schwartz, J.; Thor, M.; Zelefsky, M.; Humm, J.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Clinical outcomes in NF2-mutated RCC treated with contemporary immunotherapy regimens
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Jacobi, R.; Kotecha, R. R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Surgical quality for patients (pts) treated with neoadjuvant chemotherapy vs chemoradiation for locally advanced rectal cancer (LARC): PROSPECT (NCCTG N1048, alliance)
    Meeting Abstract

    Weiser, M.; Shi, Q.; Chang, G. J.; Hakki, L.; Goldberg, J.; Auer, R.; Gollub, M.; Saltz, L.; Musher, B. L.; Al Baghdadi, T.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Real-world outcomes and adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer
    Meeting Abstract

    Zammarrelli, W.; Ma, W.; Espino, K.; Yeoshoua, E.; Ehmann, S.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N.; Aghajanian, C.; Green, A.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • The clinicopathological and psychosocial profile of a cohort of Nigerian breast cancer survivors
    Meeting Abstract

    Wuraola, F.; Olasehinde, O.; Di Bernardo, M.; Mango, V.; Kingham, T. P.; Adisa, A.; Alatise, O.
    Cancer Epidemiology Biomarkers and Prevention (2023)

    Fulltext@MSK | Save
  • Associations of diet with survival of patients (pts) with metastatic cancer of the urothelium (mUC) and renal cell carcinoma (mRCC) on immune checkpoint blockade (ICB)
    Meeting Abstract

    Guercio, B. J.; Ratna, N.; Gavrilov, D.; Duzgol, C.; Akhlaq, M.; Teo, M. Y.; Regazzi, A. M.; Kotecha, R. R.; Funt, S. A.; Aggen, D. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Nivolumab plus cabozantinib in patients with non-clear cell renal cell carcinoma: Updated results from a phase 2 trial
    Meeting Abstract

    Lee, C. H.; Fitzgerald, K. N.; Voss, M. H.; Carlo, M. I.; Knezevic, A.; Peralta, L.; Chen, Y. B.; Zucker, M.; Lefkowitz, R. A.; Reznik, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save